P08709 (FA7_HUMAN) Homo sapiens (Human)

Coagulation factor VII UniProtKBInterProSTRINGInteractive Modelling

466 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

108 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor Heteromer
P13726;
61-466
BGC;CA;FUC; 10×TMA;0Z7;
Assess
Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor Heteromer
P13726;
61-466
BGC;CA;FUC; 22×TMA;0Z7;POL;
Assess
Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… Heteromer
P13726;
61-466
BGC;FUC;MG;CA;BEN;NA;CL;
Assess
Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… Heteromer
P13726;
61-466
BGC;FUC;MG;CA;0GE;CL;NA;
Assess
Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in … Heteromer
P13726;
61-466
GLC;FUC;MG;CA;NA;ZN;CL;PBZ;
Assess
Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. Heteromer
P13726;
61-466
GLC;FUC;MG;CA;NA;ZN;CL;BEN;
Assess
Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor Heteromer
P13726;
61-466
CA;MG;PY3;
Assess
Crystal structure of DFPR-VIIa/sTF Heteromer
P13726;
61-466
GLC;FUC;MG;CA;0G7;NA;ZN;CL;
Assess
Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607 Heteromer
P13726;
61-466
ASO;FUC;CA;24X;
Assess
Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble… Heteromer
P13726;
61-466
BGC;FUC;CA;0Z6;CAC;CL;
Assess
Human factor viia-tissue factor complexed with highly selective peptide inhibitor Heteromer
P13726;
61-466
BGC;FUC;CA;567;
Assess
Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzam… Heteromer
P13726;
61-466
BGC;FUC;CA;3BP;
Assess
Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor Heteromer
P13726;
61-466
CA;BGC;FUC;0Z6;CAC;
Assess
Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine Heteromer
P13726;
61-466
BGC;FUC;CA;P5B;
Assess
Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-… Heteromer
P13726;
61-466
BGC;FUC;CA;359;
Assess
tf7a_3771 complex Heteromer
P13726;
61-466
771;CA;CAC;FUC;BGC;
Assess
Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine Heteromer
P13726;
61-466
BGC;FUC;CA;PSM;
Assess
Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)… Heteromer
P13726;
61-466
CA;CAC;03R;
Assess
Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged grou… Heteromer
P13726;
61-466
BGC;FUC;CA;3CB;
Assess
Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine Heteromer
P13726;
61-466
BGC;FUC;CA;PI0;
Assess
Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamid… Heteromer
P13726;
61-466
BGC;FUC;CA;5PI;
Assess
Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex Heteromer
P13726;
61-466
GLC;FUC;CA;MG;0GJ;NA;ZN;CL;
Assess
tf7a_4380 complex Heteromer
P13726;
61-466
380;CA;CAC;FUC;BGC;
Assess
Rubidium Sites in Blood Coagulation Factor VIIa Heteromer
P13726;
63-466
BGC;FUC;MG;CA;RB;BEN;CL;
Assess
crystal structure of factor VII.stf complexed with pd0297121 Heteromer
P13726;
64-466
CA;GIL;GLC;FUC;NAG;
Assess
HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT Heteromer
P00974; P13726;
96-466
GLC;FUC;CA;
Assess
Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor … Heteromer
102-466
BGC;0Z6;CA;CAC;FUC;
Assess
Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor Heteromer
P13726;
107-466
6NH;
Assess
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala1… Heteromer
P13726;
107-466
CR9;
Assess
Novel 5-Azaindole Factor VIIa Inhibitors Heteromer
P13726;
107-466
7NH;
Assess
Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… Heteromer
P13726;
107-466
FUC;CA;BGC;0GE;CL;
Assess
Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble t… Heteromer
P13726;
108-466
GLC;FUC;CA;0Z6;
Assess
Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor Heteromer
P13726;
108-466
BGC;FUC;0Z6;CA;CIT;
Assess
Crystal Structure of tissue factor-factor VIIa complex Heteromer
P13726;
108-466
GLC;FUL;0Z6;NAG;CA;
Assess
Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue f… Heteromer
P13726;
109-466
BGC;FUC;CA;
Assess
Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and … Heteromer
P13726;
109-466
C1B;
Assess
Discovery of Novel Heterocyclic Factor VIIa Inhibitors Heteromer
P13726;
109-466
N1H;
Assess
STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION Heteromer
109-466
NAG;GLC;FUC;0Z6;CA;
Assess
Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4… Heteromer
147-466
70C;CA;SO4;GOL;
Assess
Factor VIIa in complex with the inhibitor 2-(2-{(R)-[(4-carbamimidoylphenyl)amino][5-ethoxy-2-fluor… Heteromer
148-466
4K1;CA;SO4;GOL;
Assess
Crystal Structure of Factor VIIa in complex with 1-(2,6-difluorophenyl)-3-[[3-[5-hydroxy-4-(1H-pyrr… Heteromer
149-466
GOL;CA;CL;SO4;7ZP;
Assess
Crystal Structure of Factor VIIa in complex with N-(6-aminopyridin-3-yl)-5-hydroxy-1-phenylpyrazole… Heteromer
149-466
SO4;GOL;CA;CL;7ZM;
Assess
Crystal Structure of Factor VIIa in complex with (2S)-2,3-dihydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[… Heteromer
149-466
SO4;GOL;CA;7Z7;CL;
Assess
Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-… Heteromer
149-466
SO4;GOL;7YA;CA;
Assess
Crystal Structure of Factor VIIa in complex with 2-phenyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-… Heteromer
149-466
GOL;CA;CL;SO4;9RP;
Assess
Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-… Heteromer
149-466
GOL;7ZD;CA;CL;SO4;
Assess
Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-[3-[(2-amino-2-… Heteromer
149-466
GOL;CA;CL;SO4;7LR;TFA;
Assess
Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-[3-[(2-amino-2-… Heteromer
149-466
GOL;CA;CL;SO4;7ZJ;
Assess
Crystal Structure of Factor VIIa in complex with phenylmethanamine;hydrochloride Heteromer
149-466
GOL;CA;CL;SO4;ABN;
Assess
Crystal Structure of Factor VIIa in complex with N-[[4-(aminomethyl)-2-(2-amino-2-oxoethoxy)phenyl]… Heteromer
149-466
CA;SO4;7YP;
Assess
Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(3-ethoxy-4-p… Heteromer
149-466
CL;GOL;CA;SO4;7ZA;
Assess
Crystal Structure of Factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-2-(3-chlorophenyl… Heteromer
149-466
7ZG;SO4;
Assess
Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(5-ethoxy-2-f… Heteromer
149-466
CL;GOL;CA;SO4;7Z1;
Assess
Crystal Structure of Factor VIIa in complex with 1-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)… Heteromer
149-466
SO4;GOL;CA;CL;7ZY;
Assess
Crystal Structure of Factor VIIa in complex with 1-(1-aminoisoquinolin-6-yl)-3-benzylurea Heteromer
149-466
CL;7XJ;CA;SO4;
Assess
Factor VIIa in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,15,17-trime… Heteromer
149-466
70A;CA;SO4;GOL;
Assess
Crystal Structure of Factor VIIa in complex with N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)… Heteromer
149-466
SO4;GOL;CA;CL;9RV;
Assess
Crystal Structure of Factor VIIa in complex with 1-[[3-[4-(5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-5… Heteromer
149-466
SO4;GOL;9S1;CA;CL;
Assess
Crystal Structure of Factor VIIa in complex with benzenecarboximidamide Heteromer
149-466
SO4;GOL;CA;BEN;
Assess
Crystal Structure of Factor VIIa in complex with 2-(4-ethoxy-3-methoxyphenyl)-2-(isoquinolin-6-ylam… Heteromer
149-466
CL;SO4;GOL;7LX;CA;
Assess
Crystal Structure of Factor VIIa in complex with cyclohexylmethanamine Heteromer
149-466
GOL;CA;CL;AMC;SO4;
Assess
Crystal Structure of Factor VIIa in complex with cyclohexanamine Heteromer
149-466
GOL;CA;CL;SO4;HAI;
Assess
Crystal Structure of Factor VIIa in complex with 1-[[3-[2-hydroxy-3-(1H-pyrrolo[3,2-c]pyridin-2-yl)… Heteromer
149-466
7XD;CL;GOL;CA;SO4;
Assess
Crystal Structure of Factor VIIa in complex with 1H-benzimidazol-2-amine Heteromer
149-466
AX7;GOL;CA;CL;SO4;
Assess
Crystal Structure of Factor VIIa in complex with isoquinoline-1,6-diamine Heteromer
149-466
CL;CA;SO4;7XM;
Assess
Crystal Structure of Factor VIIa in complex with (2R)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-… Heteromer
150-466
GOL;7YJ;CA;CL;SO4;
Assess
human factor VIIa in complex with 5-hydroxy-N-(4-oxo-3H-quinazolin-6-yl)-1-[3-[(phenylcarbamoylamin… Heteromer
150-466
GOL;7Y7;CA;CL;SO4;
Assess
Structure of factor VIIA in complex with the inhibitor 2-{2-[(1-aminoisoquinolin-6-yl)carbamoyl]-6-… Heteromer
150-466
1NK;CA;SO4;GOL;
Assess
Crystal Structure of Factor VIIa in complex with 5-hydroxy-N-(3-oxo-1,2-dihydroisoindol-5-yl)-1-[3-… Heteromer
150-466
SO4;GOL;CA;CL;7Z4;
Assess
human factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-1-[3-[[(3,5-dimethyl-1,2-oxazol-… Heteromer
150-466
GOL;CA;CL;SO4;7YM;
Assess
Structure of factor VIIA in complex with the inhibitor (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3… Heteromer
150-466
1OK;CA;SO4;GOL;
Assess
Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4… Heteromer
150-466
70D;CA;SO4;GOL;
Assess
Structure of FACTOR VIIA in complex with the inhibitor BMS-593214 also known as 2'-[(6R,6AR,11BR)-2… Heteromer
150-466
1GE;CA;
Assess
Structure of factor VIIA in complex with the inhibitor 2-{2-[(3-carbamoylphenyl)carbamoyl]-6-methox… Heteromer
150-466
1NL;CA;SO4;GOL;
Assess
human factor VIIa in complex with 1-[[3-[5-hydroxy-4-(7H-pyrrolo[2,3-d]pyrimidin-6-yl)pyrazol-1-yl]… Heteromer
150-466
GOL;9RY;CA;CL;SO4;
Assess
Factor VIIa in complex with the inhibitor (11R)-11-[(1-aminoisoquinolin-6-yl)amino]-16-(cyclopropyl… Heteromer
150-466
7KR;CA;SO4;GOL;
Assess
Factor VIIa in complex with the inhibitor (5R,11R)-11-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-16-… Heteromer
150-466
7KS;CA;SO4;GOL;
Assess
Factor VIIa in complex with the inhibitor (5R)-5-[(1-aminoisoquinolin-6-yl)amino]-19-(cyclopropylsu… Heteromer
150-466
7KQ;CA;SO4;GOL;
Assess
Structure of FACTOR VIIA in complex with the inhibitor (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(C… Heteromer
150-466
1GG;CA;
Assess
Factor VIIA in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-8-fluoro-7-hy… Heteromer
150-466
67O;CA;SO4;MES;
Assess
FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,11-diazatricycl… Heteromer
150-466
4T1;CA;SO4;GOL;
Assess
Factor VIIa in complex with the inhibitor 4-{[(R)-[5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl](4-ph… Heteromer
150-466
4JY;CA;SO4;GOL;
Assess
FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID Heteromer
150-466
3ZB;CA;SO4;GOL;
Assess
FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 4-BROMO-2-METHOXYPHENOL Heteromer
150-466
3Z7;CA;SO4;GOL;
Assess
Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(pr… Heteromer
150-466
2KF;CA;SO4;GOL;
Assess
Structure of factor VIIA in complex with the inhibitor (2R)-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2… Heteromer
150-466
1OJ;CA;SO4;GOL;
Assess
Structure of factor VIIA in complex with the inhibitor 2-{2-[(4-carbamimidoylphenyl)carbamoyl]-6-me… Heteromer
150-466
1NJ;CA;SO4;GOL;
Assess
FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 7-chloro-3,4-dihydroisoquinolin-1(2H)-one Heteromer
150-466
3Z8;CA;SO4;GOL;
Assess
Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(pr… Heteromer
150-466
2KE;CA;SO4;GOL;
Assess
Factor VIIa in complex with the inhibitor 3'-amino-5'-[(2s,4r)-6-carbamimidoyl-4-phenyl-1,2,3,4-tet… Heteromer
150-466
1T7;CA;
Assess
Crystal structure of active site-inhibited human coagulation factor VIIA (DES-GLA) Heteromer
150-466
0GE;CA;
Assess
Factor VIIa in complex with the inhibitor 3-{[(2R)-17-ethyl-4-methyl-3,12-dioxo-7-[(propan-2-yl)sul… Heteromer
150-466
82J;CA;SO4;GOL;
Assess
human factor VIIa in complex with 1-[[3-[5-hydroxy-3-methyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazo… Heteromer
150-466
GOL;9RS;CA;CL;SO4;
Assess
FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (methyl {3-[(2R)-1-{(2R)-2-(3,4-dimethoxyphenyl)-2-[(1-ox… Heteromer
150-466
3Z9;CA;SO4;GOL;
Assess
FACTOR VIIA IN COMPLEX WITH THE INHIBITOR N-{3-[(2R)-1-{(2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-p… Heteromer
150-466
4T0;CA;SO4;
Assess
human POGLUT1 in complex with Factor VII EGF1 and UDP Heteromer
Q8NBL1;
107-145
NAG;UDP;CL;GOL;CA;
Assess
Cofactor-and substrate-assisted activation of factor VIIahomo-2-mer144-466
SO4;CA;BEN;GOL;
Assess
Factor7 - 413 complexhomo-2-mer148-466
CA;413;
Assess
Crystal structure of uninhibited factor VIIahomo-2-mer149-466
CA;EDO;
Assess
Orally available Factor7a inhibitorhomo-2-mer150-466
346;SO4;CA;
Assess
Factor7 - 413 complexhomo-2-mer150-466
GOL;CA;413;SO4;
Assess
Coagulation Factor VII Zymogen (EGF2/Protease) in Complex with Inhibitory Exosite Peptide A-183homo-2-mer150-466
SO4;BEN;
Assess
Short Factor VIIa with a small molecule inhibitorhomo-2-mer150-466
CA;SO4;905;
Assess
THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, MINIMIZED AVERAGE STRUCTUREmonomer105-147
Assess
THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, 20 STRUCT…monomer105-147
FUC;
Assess
THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, MINIMIZED…monomer105-147
FUC;
Assess
THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, 20 STRUCTURESmonomer105-147
Assess
N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURESmonomer105-145
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4jzd.1.Amonomer0.88213-466
1NJ;CA;100.00
Assess
4o03.1.Amonomer0.5561-454
CA;33.76
Assess
5edm.1.Amonomer0.5461-455
34.45
Assess
5edk.1.Amonomer0.5466-455
33.68
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25edm.1.Amonomer0.5439-433
34.45
Assess
Isoform 25edk.1.Amonomer0.5344-433
33.68
Assess